These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6112449)

  • 1. Rubella viraemia and antibody responses after rubella vaccination and reimmunization.
    Balfour HH; Groth KE; Edelman CK; Amren DP; Best JM; Banatvala JE
    Lancet; 1981 May; 1(8229):1078-80. PubMed ID: 6112449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of rubella antibodies after vaccination: detection after experimental challenge.
    Banatvala JE; Best JM; O'Shea S; Dudgeon JA
    Rev Infect Dis; 1985; 7 Suppl 1():S86-90. PubMed ID: 4001741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viremia, virus excretion, and antibody responses after challenge in volunteers with low levels of antibody to rubella virus.
    O'Shea S; Best JM; Banatvala JE
    J Infect Dis; 1983 Oct; 148(4):639-47. PubMed ID: 6355309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenge with rubella virus after loss of detectable vaccine-induced antibody.
    Schiff GM; Young BC; Stefanovic' GM; Stamler EF; Knowlton DR; Grundy BJ; Dorsett PH
    Rev Infect Dis; 1985; 7 Suppl 1():S157-63. PubMed ID: 4001723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rubella vaccination: persistence of antibodies for up to 16 years.
    O'Shea S; Best JM; Banatvala JE; Marshall WC; Dudgeon JA
    Br Med J (Clin Res Ed); 1982 Jul; 285(6337):253-5. PubMed ID: 6807437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rubella in Orkney: seroepidemiology and vaccination.
    Moffat MA; Heywood SN; Laughton E; Gould JJ; Freestone DS
    J Hyg (Lond); 1977 Jun; 78(3):419-27. PubMed ID: 266542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological response to rubella revaccination.
    Serdula MK; Halstead SB; Wiebenga NH; Herrmann KL
    JAMA; 1984 Apr; 251(15):1974-7. PubMed ID: 6700099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunoglobulin M response to rubella vaccine in young adult women.
    Mortimer PP; Edwards JM; Porter AD; Tedder RS; Haslehurst J
    J Hyg (Lond); 1984 Jun; 92(3):277-83. PubMed ID: 6376624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunoglobulin response to reimmunization with rubella vaccine.
    Scott RM; Schydlower M; Lampe RM; Schwab JA; Muelenaer AA
    J Pediatr; 1981 Oct; 99(4):531-4. PubMed ID: 7277092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are many women immunized against rubella unnecessarily?
    Mortimer PP; Edwards JM; Porter AD; Tedder RS; Mace JE; Hutchinson A
    J Hyg (Lond); 1981 Aug; 87(1):131-8. PubMed ID: 7019319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological response to rubella revaccination in adolescent females.
    Fitzpatrick SB; Anthony R; Heald F
    J Adolesc Health Care; 1983 Sep; 4(3):168-70. PubMed ID: 6629973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rubella: immunity and vaccination in schoolgirls.
    Kudesia G; Robinson ET; Wilson WD; Wilson TS; Stewart IM; Campbell AT; Thomson W; Silver M; Reid D; Urquhart GE
    Br Med J (Clin Res Ed); 1985 May; 290(6479):1406-8. PubMed ID: 3922513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rubella immunity by four different techniques: results of challenge studies.
    Best JM; Harcourt GC; Druce A; Palmer SJ; O'Shea S; Banatvala JE
    J Med Virol; 1980; 5(3):239-47. PubMed ID: 7014779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current chemotherapy protocols for childhood acute lymphoblastic leukemia induce loss of humoral immunity to viral vaccination antigens.
    Nilsson A; De Milito A; Engström P; Nordin M; Narita M; Grillner L; Chiodi F; Björk O
    Pediatrics; 2002 Jun; 109(6):e91. PubMed ID: 12042585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and persistence of class-specific antibodies in the serum and nasopharyngeal washings of rubella vaccinees.
    O'Shea S; Best JM; Banatvala JE; Shepherd WM
    J Infect Dis; 1985 Jan; 151(1):89-98. PubMed ID: 3965597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duration of immunity after rubella vaccination: a long-term study in Switzerland.
    Just M; Just V; Berger R; Burkhardt F; Schilt U
    Rev Infect Dis; 1985; 7 Suppl 1():S91-4. PubMed ID: 4001742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trial of high-titre human rubella immunoglobulin.
    Urquhart GE; Crawford RJ; Wallace J
    Br Med J; 1978 Nov; 2(6148):1331-2. PubMed ID: 363233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further evaluation of the optimum age for rubella vaccine administration.
    Wilkins J; Wehrle PF
    Am J Dis Child; 1979 Dec; 133(12):1237-9. PubMed ID: 517472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of vaccine-induced immune responses to rubella: comparison with natural infection.
    Horstmann DM; Schluederberg A; Emmons JE; Evans BK; Randolph MF; Andiman WA
    Rev Infect Dis; 1985; 7 Suppl 1():S80-5. PubMed ID: 4001740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rubella-specific serum and nasopharygeal immunoglobulin responses following naturally acquired and vaccine-induced infection. Prolonged persistence of virus-specific IgM.
    Al-Nakib W; Best JM; Banatvala JE
    Lancet; 1975 Jan; 1(7900):182-5. PubMed ID: 47417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.